block
verse
w
o
rdys
billionaire
.ai
your
list
Whiteboard
App
quizie
un
school
New Journal
News
Home
Popular
Elections
Share
Genius — OpenServe
Sponsored
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 Clinical Trial — latest news, discussion & facts — IJR
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 Clinical Trial
Share
scholarly article
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 Clinical Trial
scientific article published on March 21, 2012
Ask Genius
Site
Site
Journal
Feed
Discussions
About
Sort by
Content type
Latest Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 Clinical Trial news and discussion
Sort by
Content type
Nothing published yet
The conversation starts anyway — post the first discussion above.
